- Business Wire•4 days ago
BioTime, Inc. , a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that it will release first quarter financial and operating results on Wednesday, May 10, 2017, after the close of the U.S.
- Business Wire•6 days ago
BioTime, Inc. , a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that an abstract related to the Company’s retinal tissue implant has been accepted for a paper presentation at the Annual Meeting of the Association for Research in Vision and Ophthalmology in Baltimore, Maryland, May 7-11.
- Capital Cube•10 days ago
Categories: Europe Stock Alerts Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for BioTime, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
BTX : Summary for BioTime, Inc. - Yahoo Finance
BioTime, Inc. (BTX)
NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
|Day's Range||3.34 - 3.46|
|52 Week Range||2.26 - 4.01|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||10.00|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|